Suzuki Ayako

スズキアヤコ | Suzuki Ayako

Affiliation and department：

Research field (1)： Systems genomics

Research theme for competitive and other funds (11)：

2022 - 2025 Elucidation of the molecular basis of MYC-driven cancers and development of therapeutic strategies
2022 - 2025 がん放射線治療後に起きる免疫応答経路の選択に関わる分子の探索
2022 - 2024 Analysis of network between microenvironmental-cancer cell network in solid cancers
2020 - 2024 Identification of novel driver genes by whole genome sequencing of early stage lung tumors
2021 - 2023 肺がん組織における空間的遺伝子発現および局所変異解析手法の構築

Show all

Papers (64)：

Sakurako Suma, Yasuhito Suehara, Manabu Fujisawa, Yoshiaki Abe, Keiichiro Hattori, Kenichi Makishima, Tatsuhiro Sakamoto, Aya Sawa, Hiroko Bando, Daisuke Kaji, et al. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution. Leukemia. 2024. 38. 2. 340-350
Hidekazu Oyoshi, Junyan Du, Shunsuke A Sakai, Riu Yamashita, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa, et al. Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma. Science advances. 2023. 9. 50. eadh9069
Yasuhiko Haga, Yoshitaka Sakamoto, Keiko Kajiya, Hitomi Kawai, Miho Oka, Noriko Motoi, Masayuki Shirasawa, Masaya Yotsukura, Shun-Ichi Watanabe, Miyuki Arai, et al. Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. Nature communications. 2023. 14. 1. 8375-8375
Junyan Du, Shun-Ichiro Kageyama, Riu Yamashita, Kosuke Tanaka, Masayuki Okumura, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Hidenari Hirata, Hironori Sunakawa, et al. Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. Communications biology. 2023. 6. 1. 818-818
Yu Tanaka, Tokiko Nakai, Ayako Suzuki, Yosuke Kagawa, Osamu Noritake, Tetsuro Taki, Hiroko Hashimoto, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, et al. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma. Cancer immunology, immunotherapy : CII. 2023. 72. 7. 2205-2215

ｍore...

MISC (25)：

大岩宏聡, 青景圭樹, 鈴木絢子, 三牧幸代, 三好智裕, 多根健太, 鮫島譲司, 土原一哉, 後藤功一, 坪井正博, et al. 壊死を伴うstageI期肺腺癌の臨床病理学的特徴,遺伝子発現および遺伝学的特徴についての検討. 肺癌. 2021. 61. 6. 657-657
武藤杏子, 永澤慧, 永澤慧, 鈴木穣, 鈴木絢子, 関真秀. Semibulk RNA-seq analysis as a convenient method for measuring gene expression statuses in a local cellular environment. 日本分子生物学会年会プログラム・要旨集(Web). 2021. 44th
関真秀, 坂本祥駿, 座波紗子, 永澤慧, 鈴木絢子, 鈴木穣. Development of method for whole-genome long-read methylation analysis from small amount of DNA. 日本分子生物学会年会プログラム・要旨集(Web). 2021. 44th
山岸誠, 鈴木穣, 窪川美雪, 久世裕太, 横溝明香里, 鈴木絢子, 小林誠一郎, 中島誠, 宇都宮與, 森島聡子, et al. 多層シングルセルプラットフォームによるクローン構造解析とTCR経路変異の生物学的意義の検討. 日本癌学会総会記事. 2020. 79回. OE7-7
山盛智子[森田], 大橋紹宏, 波江野洋, 牧野嶋秀樹, 鈴木絢子, 小林進. がん細胞内の代謝変化が関与する染色体不安定性ストレスへの適応機構. 日本癌学会総会記事. 2020. 79回. PJ6-8

ｍore...

Professional career (1)：

博士(生命科学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page